Literature DB >> 6708260

Prevention of uterine perforation during curettage abortion.

D A Grimes, K F Schulz, W J Cates.   

Abstract

Although uterine perforation is a potentially life-threatening complication of curettage abortion, little is known about the risk factors associated with uterine perforation or how to prevent it. Using linear logistic regression, we analyzed 67,175 curettage abortions performed at 13 institutions in the United States from 1975 through 1978. The overall incidence of confirmed perforation was 0.9 per 1,000 abortions. Performance of the abortion by a resident rather than by an attending physician was a powerful risk factor for perforation (relative risk, 5.5; 95% confidence interval, 3.3 to 9.2). Use of Laminaria for dilation had a protective effect, although this effect was not statistically significant (relative risk, 0.17; 95% confidence interval, 0.02 to 1.2). Among factors beyond the control of the physician, advancement of gestational age and previous delivery were significant risk factors. Use of Laminaria and performance of the abortion by an attending physician considerably lowered the risk of uterine perforation.

Entities:  

Mesh:

Year:  1984        PMID: 6708260

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  Uterine perforation and small bowel incarceration: sonographic and surgical findings.

Authors:  Suzanne G Shulman; Carrie L Bell; Frederick E Hampf
Journal:  Emerg Radiol       Date:  2006-08-16

2.  Safety of aspiration abortion performed by nurse practitioners, certified nurse midwives, and physician assistants under a California legal waiver.

Authors:  Tracy A Weitz; Diana Taylor; Sheila Desai; Ushma D Upadhyay; Jeff Waldman; Molly F Battistelli; Eleanor A Drey
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

Review 3.  Imaging evaluation of uterine perforation and rupture.

Authors:  Hassan Aboughalia; Deepashri Basavalingu; Margarita V Revzin; Laura E Sienas; Douglas S Katz; Mariam Moshiri
Journal:  Abdom Radiol (NY)       Date:  2021-06-15

4.  Paracervical Block for Laminaria Insertion Before Second-Trimester Abortion: A Randomized Controlled Trial.

Authors:  Reni Soon; Mary Tschann; Jennifer Salcedo; Katelyn Stevens; Hyeong Jun Ahn; Bliss Kaneshiro
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

Review 5.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

6.  Factors associated with immediate abortion complications.

Authors:  L E Ferris; M McMain-Klein; N Colodny; G F Fellows; J Lamont
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

7.  Uses of misoprostol in obstetrics and gynecology.

Authors:  Rebecca Allen; Barbara M O'Brien
Journal:  Rev Obstet Gynecol       Date:  2009

8.  A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

9.  Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.

Authors:  K S Oppegaard; B-I Nesheim; O Istre; E Qvigstad
Journal:  BJOG       Date:  2008-01-16       Impact factor: 6.531

10.  Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomised, placebo-controlled sequential trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2008-06       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.